Insa Winzenborg

Publication Activity (10 Years)

Years Active: 2019-2024
Publications (10 Years): 10

Top Topics

Ulcerative Colitis

Top Venues

Clinical and translational science

Clinical pharmacokinetics

Clinical pharmacology and therapeutics

CPT: pharmacometrics & systems pharmacology

This page only lists publications with an associated author ORCID identifier.

Publications

Yinuo Pang, Ronilda R D'Cunha, Insa Winzenborg, Geertruida Veldman, Valerie Pivorunas, Kori Wallace
Risankizumab: Mechanism of action, clinical and translational science. Clinical and translational science 17 (1) (2024)
Yinuo Pang, Ronilda R D'Cunha, Insa Winzenborg, Geertruida Veldman, Valerie Pivorunas, Kori Wallace
Risankizumab: Mechanism of action, clinical and translational science. Clinical and translational science 17 (1) (2024)
Yinuo Pang, Ronilda R D'Cunha, Insa Winzenborg, Geertruida Veldman, Valerie Pivorunas, Kori Wallace
Risankizumab: Mechanism of action, clinical and translational science. Clinical and translational science 17 (1) (2024)
Neha Thakre, Aline Goebel, Insa Winzenborg, Ahmed A Suleiman, Ronilda R D'Cunha, Sven Mensing, Wei Liu, Yinuo Pang
Population Pharmacokinetic and Exposure-Response Modeling to Inform Risankizumab Dose Selection in Patients With Ulcerative Colitis. Clinical pharmacology and therapeutics 116 (3) (2024)
Neha Thakre, Aline Goebel, Insa Winzenborg, Ahmed A Suleiman, Ronilda R D'Cunha, Sven Mensing, Wei Liu, Yinuo Pang
Population Pharmacokinetic and Exposure-Response Modeling to Inform Risankizumab Dose Selection in Patients With Ulcerative Colitis. Clinical pharmacology and therapeutics (2024)
Denise Beck, Insa Winzenborg, Wei Gao, Nael M Mostafa, Stephanie E Chiuve, Charlotte Owens, Mohamad Shebley
Interdisciplinary model-informed drug development for extending duration of elagolix treatment in patients with uterine fibroids. British journal of clinical pharmacology 88 (12) (2022)
Denise Beck, Insa Winzenborg, Mohan Liu, Jacob F Degner, Nael M Mostafa, Peter Noertersheuser, Mohamad Shebley
Population Pharmacokinetics of Elagolix in Combination with Low-Dose Estradiol/Norethindrone Acetate in Women with Uterine Fibroids. Clinical pharmacokinetics (2021)
Mohamad Shebley, Akshanth R Polepally, Ahmed Nader, Juki W Ng, Insa Winzenborg, Cheri E Klein, Peter Noertersheuser, Megan A Gibbs, Nael M Mostafa
Clinical Pharmacology of Elagolix: An Oral Gonadotropin-Releasing Hormone Receptor Antagonist for Endometriosis. Clinical pharmacokinetics 59 (3) (2021)
Insa Winzenborg, Akshanth R Polepally, Ahmed Nader, Nael M Mostafa, Peter Noertersheuser, Juki W Ng
Effect of Elagolix Exposure on Clinical Efficacy End Points in Phase III Trials in Women With Endometriosis-Associated Pain: An Application of Markov Model. CPT: pharmacometrics & systems pharmacology 9 (8) (2020)
Insa Winzenborg, Ahmed Nader, Akshanth R Polepally, Mohan Liu, Jacob Degner, Cheri E Klein, Nael M Mostafa, Peter Noertersheuser, Juki Ng
Population Pharmacokinetics of Elagolix in Healthy Women and Women with Endometriosis. Clinical pharmacokinetics 57 (10) (2019)